Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sabrina L Browning"'
Autor:
Neima Briggs, Michael V Gormally, Fangyong Li, Sabrina L Browning, Miriam M Treggiari, Alyssa Morrison, Maudry Laurent-Rolle, Yanhong Deng, Jeanne E Hendrickson, Christopher A Tormey, Mahalia S Desruisseaux
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254453 (2021)
BackgroundLimited therapeutic options exist for coronavirus disease 2019 (COVID-19). COVID-19 convalescent plasma (CCP) is a potential therapeutic, but there is limited data for patients with moderate-to-severe disease.Research questionWhat are outco
Externí odkaz:
https://doaj.org/article/211cd90bb2b44e64a0d4f2c6cc5ea7da
Autor:
Sabrina L. Browning, Yuxin Liu, Terri L. Parker, Noffar Bar, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Ria Syam, Elan Gorshein, Autumn DiAdamo, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Wei Wei, Andrew Haims, Natalia Neparidze
Publikováno v:
Blood. 140:7308-7310
Autor:
David Furfaro, Coral Olazagasti, Shonali Midha, Emily F. Collier, Rita Paschal, Nausheen Hakim, Christine M. Lovly, Jess DeLaune, Samuel M. Rubinstein, Charles Bodine, Shreya Prasad Goyal, Jori May, Nagashree Seetharamu, Sabrina L. Browning, Laura A. Sena, Deepa Rangachari, Michael J. Grant, Shuai Qin, Leo Reap, Martina Murphy, Frances A. Collichio, Mario A. Davidson, Samuel B Brusca, Stephen Kimani, Jennifer R. Green, Elizabeth Henry, Rushad Patell, Monica Sheila Chatwal, Jill Gilbert, Richard L. Martin, Nikesh N. Shah
Publikováno v:
JCO Oncol Pract
PURPOSE:COVID-19 challenged medical practice and graduate medical education. Building on previous initiatives, we describe and reflect on the formative process and goals of the Hematology-Oncology Collaborative Videoconferencing Learning Initiative,
Autor:
Yuxin Liu, Sabrina L. Browning, Jennifer VanOudenhove, Giulia Biancon, Noffar Bar, Terri L. Parker, Tara Anderson, Madhav Dhodapkar, Stuart Seropian, Stephanie Halene, Mina L Xu, Elan Gorshein, Ashita Talsania, Wajih Zaheer Kidwai, David H. Witt, Victor Chang, Francesca Montanari, Andrew Lischuk, Andrew Haims, Wei Wei, Natalia Neparidze
Publikováno v:
Blood. 140:7086-7087
Autor:
Jeanne E. Hendrickson, Alyssa Morrison, Fangyong Li, Sabrina L. Browning, Miriam M. Treggiari, Mahalia S. Desruisseaux, Neima Briggs, Christopher A. Tormey, Michael V. Gormally, Yanhong Deng, Maudry Laurent-Rolle
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254453 (2021)
PLoS ONE
PLoS ONE
Background Limited therapeutic options exist for coronavirus disease 2019 (COVID-19). COVID-19 convalescent plasma (CCP) is a potential therapeutic, but there is limited data for patients with moderate-to-severe disease. Research question What are ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9321560b725bb20e1b5b092700f029f8
https://doi.org/10.1101/2021.06.16.21258972
https://doi.org/10.1101/2021.06.16.21258972
Autor:
Karl L. Insogna, Sabrina L. Browning, Natalia Neparidze, Elan Gorshein, Noffar Bar, Terri L. Parker, Tara Anderson, Anna Poteraj, Talib Dosani
Publikováno v:
Blood. 138:4756-4756
Introduction: Skeletal-related events (SREs) can cause significant morbidity and adversely impact quality of life in patients with multiple myeloma (MM). The bisphosphonate zoledronic acid (ZOL) has historically been the most widely used agent to pre
Autor:
Gregory K. Buller, Miriam M. Treggiari, Mohammad Khan, Alyssa Morrison, Joseph B Ladines-Lim, Mahalia S. Desruisseaux, Christopher A. Tormey, Michael V. Gormally, Sabrina L. Browning, Prakash Kandel, Maudry Laurent-Rolle, Jeanne E. Hendrickson, Alan Zakko, Kent A. Owusu, Neima Briggs, Muyi Li, Gavin X. McLeod
Publikováno v:
Blood
Background: Coronavirus disease 2019 (COVID-19), a multi-system disorder resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected 5.0 million individuals in the United States (US) resulting in more than
Autor:
Tara Anderson, Sabrina L. Browning, Noffar Bar, Stuart Seropian, Natalia Neparidze, Terri L. Parker, Alfred Ian Lee
Publikováno v:
Blood. 134:5569-5569
Background: Multiple myeloma (MM) is an incurable and heterogeneous neoplasm of clonal plasma cells. Fortunately, the introduction of novel therapeutic agents has altered the landscape of MM with resultant improvements in both overall survival and qu